Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing somatostatin analog (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Somatostatin analog (substance) |
Inferred relationship |
Some |
1 |
Lanreotide (substance) |
Is a |
True |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|
Pentetreotide (substance) |
Is a |
True |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|
Depreotide (substance) |
Is a |
True |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|
Octreotide |
Is a |
True |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|
Pasireotide |
Is a |
True |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|
Lutetium (177-Lu) labeled somatostatin analog |
Is a |
False |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|
Yttrium (90-Y) labeled somatostatin analog (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|
Octreotide acetate |
Is a |
True |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|
Pasireotide pamoate (substance) |
Is a |
True |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|
Pasireotide diaspartate |
Is a |
True |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|
Lanreotide acetate (substance) |
Is a |
True |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|
Lutetium (177-Lu) labeled somatostatin analog |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|
Radiolabelled octreotide |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|
Radioisotope labeled somatostatin analog (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|
Gallium (68-Ga) labelled somatostatin analogue |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|
Copper (64-Cu) labeled somatostatin analog (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|
Technetium (99m-Tc) labeled somatostatin analog |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Somatostatin analog (substance) |
Inferred relationship |
Some |
|